Current
2.8×
5-Year Average
4.7×
All-Time High
11.1×
All-Time Low
0.7×
P/B Ratio daily chart for Boston Scientific (BSX)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/B Ratio for Boston Scientific (BSX) from 2001 to 2025
| 2025 | $141.38B | $24.23B | 5.8× | -0.2× | |
| 2024 | $131.68B | $21.77B | 6.0× | +1.7× | |
| 2023 | $84.71B | $19.28B | 4.4× | +0.6× | |
| 2022 | $66.29B | $17.57B | 3.8× | +0.1× | |
| 2021 | $60.54B | $16.62B | 3.6× | +0.3× | |
| 2020 | $51.33B | $15.33B | 3.3× | -1.2× | |
| 2019 | $63.05B | $13.88B | 4.5× | -1.1× | |
| 2018 | $48.92B | $8.72B | 5.6× | +0.8× | |
| 2017 | $34.04B | $7.01B | 4.9× | +0.5× | |
| 2016 | $29.46B | $6.73B | 4.4× | +0.6× | |
| 2015 | $23.87B | $6.32B | 3.8× | +1.2× | |
| 2014 | $17.58B | $6.84B | 2.6× | +0.1× | |
| 2013 | $15.98B | $6.54B | 2.4× | +1.3× | |
| 2012 | $7.83B | $6.87B | 1.1× | +0.5× | |
| 2011 | $7.72B | $11.35B | 0.7× | -0.3× | |
| 2010 | $11.56B | $11.30B | 1.0× | -0.1× | |
| 2009 | $13.60B | $12.30B | 1.1× | +0.2× | |
| 2008 | $11.62B | $13.17B | 0.9× | -0.3× | |
| 2007 | $17.38B | $15.10B | 1.2× | -0.5× | |
| 2006 | $25.26B | $15.30B | 1.7× | -3.1× | |
| 2005 | $20.33B | $4.28B | 4.7× | -2.6× | |
| 2004 | $29.60B | $4.03B | 7.4× | -3.5× | |
| 2003 | $31.01B | $2.86B | 10.8× | +3.9× | |
| 2002 | $17.19B | $2.47B | 7.0× | +2.1× | |
| 2001 | $9.89B | $2.02B | 4.9× | — |
- 20255.8×
- 20246.0×
- 20234.4×
- 20223.8×
- 20213.6×
- 20203.3×
- 20194.5×
- 20185.6×
- 20174.9×
- 20164.4×
- 20153.8×
- 20142.6×
- 20132.4×
- 20121.1×
- 20110.7×
- 20101.0×
- 20091.1×
- 20080.9×
- 20071.2×
- 20061.7×
- 20054.7×
- 20047.4×
- 200310.8×
- 20027.0×
- 20014.9×
About P/B Ratio at Boston Scientific (BSX)
Boston Scientific (BSX) P/B ratio is 2.8× as of June 5, 2026. The 5-year average is 4.7×. The sector median currently stands at 3.4×. The current ratio is at the 0th percentile of its own 10-year history.
Boston Scientific (BSX) historical P/B ratio has ranged from a low of 0.7× (2011) to a high of 11.1× (2004) in the available daily series.
The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.
Boston Scientific P/B Ratio by Year
Boston Scientific P/B Ratio 2025: 5.8×
Boston Scientific (BSX) P/B ratio in 2025 was 5.8×, contracted from 6.0× the prior year.
Boston Scientific P/B Ratio 2024: 6.0×
Boston Scientific (BSX) P/B ratio in 2024 was 6.0×, expanded from 4.4× the prior year.
Boston Scientific P/B Ratio 2023: 4.4×
Boston Scientific (BSX) P/B ratio in 2023 was 4.4×, expanded from 3.8× the prior year.
Boston Scientific P/B Ratio 2022: 3.8×
Boston Scientific (BSX) P/B ratio in 2022 was 3.8×, expanded from 3.6× the prior year.
Boston Scientific P/B Ratio 2021: 3.6×
Boston Scientific (BSX) P/B ratio in 2021 was 3.6×.
Sector peers by P/B Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/B Ratio — table
Healthcare peers of Boston Scientific (BSX), ranked by P/B ratio.
| 2.9× | |
| 2.7× | |
| 2.6× | |
| 2.6× | |
| 2.5× | |
| 2.5× | |
| 2.4× | |
| 2.4× | |
| 2.3× | |
| 1.8× | |
| 1.8× | |
| 1.7× | |
| 1.7× | |
| 1.6× | |
| 1.5× | |
| 1.5× | |
| 1.5× | |
| 1.4× | |
| 1.4× | |
| 1.4× | |
| 1.2× | |
| 1.2× | |
| 1.1× | |
| 1.1× | |
| 0.8× |
- 2.7×
- 2.4×
- 2.3×
- 1.8×
- 1.7×
- 1.4×
- 1.4×
- 1.2×
- 1.1×
- 1.1×
- 0.8×
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric